Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Magnesium Sulfate for Postoperative Analgesia in Total Hip Replacement
NCT00560092Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jan 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in postoperative pain (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Reduction of morphine consumption in the postoperative period. Started Jan 2004; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00560092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560092.